OFIX · Orthofix Medical Inc. · Executive Compensation
$9.40
-0.01 (-0.11%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$384.52M
Shares
40.73M
Volume · Oct 1
16.27K
Avg daily vol (3M)
372.48K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Vickie Capps | director | Appointed | 2025-03-12 |
| John B. Henneman, III | Chair of the Nominating, Governance and Sustainability Committee of the Board | Appointed | 2024-06-20 |
| Jason M. Hannon | Chair of the Compliance and Ethics Committee of the Board | Appointed | 2024-06-20 |
| Charles R. Kummeth | Chair of the Compensation and Talent Development Committee of the Board | Appointed | 2024-06-20 |
| Wayne Burris | Chair of the Audit and Finance Committee of the Board | Appointed | 2024-06-20 |
| Michael M. Finegan | Chair of the Board | Appointed | 2024-06-20 |
| Julie Andrews | Chief Financial Officer | Appointed | 2024-01-17 |
| Julie Andrews | Chief Financial Officer | Appointed | 2024-01-17 |
| Julie Andrews | Chief Financial Officer | Appointed | 2024-01-09 |
| Massimo Calafiore | Director | Appointed | 2024-01-09 |
| Massimo Calafiore | President and Chief Executive Officer | Appointed | 2024-01-09 |
| Charles Kummeth | independent director | Appointed | 2023-12-15 |
| Michael Finegan | independent director | Appointed | 2023-12-15 |
| Alan Bazaar | independent director | Appointed | 2023-12-15 |
| Charles R. Kummeth | director | Appointed | 2023-12-15 |
| Michael M. Finegan | director | Appointed | 2023-12-15 |
| Alan L. Bazaar | director | Appointed | 2023-12-15 |
| Massimo Calafiore | President and Chief Executive Officer | Appointed | 2023-12-01 |
| Keith C. Valentine | member of the Board of Directors | Resigned | 2023-10-05 |
| Geoffrey C. Gillespie | Interim Chief Financial Officer | Appointed | 2023-09-14 |
| Puja Leekha | Interim Chief Legal Officer | Appointed | 2023-09-14 |
| Patrick Keran | Chief Legal Officer | Terminated | 2023-09-14 |
| Catherine M. Burzik | Interim Chief Executive Officer | Appointed | 2023-09-14 |
| John Bostjancic | Chief Financial Officer | Terminated | 2023-09-14 |
| Keith Valentine | Chief Executive Officer | Terminated | 2023-09-14 |